RSSArticle Type

Editor’s Message—Issue Highlights, March–April 2017

Editor’s Message—Issue Highlights, March–April 2017

| April 1, 2017 | 0 Comments

Dear Colleagues: Welcome to the March–April 2017 issue of Innovations in Clinical Neuroscience. We start this issue with an interesting case series by Shroff titled, “Human Embryonic Stem Cells in the Treatment of Autism: A Case Series.” Here, investigators administered human embryonic stem cell therapy to three children with autism spectrum disorder (ASD) in an […]

Continue Reading

Human Embryonic Stem Cells in the Treatment of Autism:  A Case Series

Human Embryonic Stem Cells in the Treatment of Autism: A Case Series

| April 1, 2017 | 0 Comments

by Geeta Shroff, MD Dr. Shroff is Director of Nutech Mediworld in New Delhi, India. Innov Clin Neurosci. 2017;14(3–4):12–16 Funding: No funding was received for the preparation of this article. Financial disclosures: The author has no conflicts of interest relevant to the content of this article. Key words: Autism, human embryonic stem cell, hESC, stem […]

Continue Reading

Interactive Voice Response and Text-based Self-report Versions of the Electronic Columbia-Suicide Severity Rating Scale Are Equivalent

Interactive Voice Response and Text-based Self-report Versions of the Electronic Columbia-Suicide Severity Rating Scale Are Equivalent

| April 1, 2017 | 0 Comments

by Chad Gwaltney, PhD; James C Mundt, PhD; John H. Greist, MD; Jean Paty, PhD; and Brian Tiplady, PhD  Dr. Gwaltney is with Gwaltney Consulting, Westerly, Rhode Island (with ERT Inc. during the time of this study); Dr. Mundt is with ePRO Research Consulting, LLC, Sauk City, Wisconsin; Dr. Greist is Professor Emeritus of Psychiatry, University […]

Continue Reading

Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

| April 1, 2017 | 0 Comments

by Jagannadha Avasarala, MD, PhD Dr. Avasarala is with the Department of Internal Medicine, Division of Neurology, Greenville Health System, Neuroscience Associates, in Greenville, South Carolina. Innov Clin Neurosci. 2017;14(3–4):38–40 Funding: No funding was received for the preparation of this article. Financial disclosures: The author has no conflicts of interest relevant to the content of […]

Continue Reading

Managing Your Aging  Patient Population

Managing Your Aging Patient Population

| April 1, 2017 | 0 Comments

by Ann L. McNary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Innov Clin Neurosci. 2017;14(3–4)41–44 This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by PRMS, Inc. (www.prms.com), a […]

Continue Reading

Letter to the editor: Modafinil Augmentation Therapy in Patient with Traumatic Brain Injury

Letter to the editor: Modafinil Augmentation Therapy in Patient with Traumatic Brain Injury

| April 1, 2017 | 0 Comments

Innov Clin Neurosci. 2017;14(3–4):11 Dear Editor: Traumatic brain injury (TBI) is a significant cause of morbidity and mortality. Annually, more than two million people in the United States will sustain a TBI, and approximately one quarter of those will require hospitalization. Of those who survive TBI, many continue to suffer from a variety of symptoms, […]

Continue Reading

CNS Summit 2016 Abstracts of Poster Presentations

CNS Summit 2016 Abstracts of Poster Presentations

| February 1, 2017 | 0 Comments

Innov Clin Neurosci. 2017;14(1–2)3–23 A MESSAGE FROM THE EDITOR Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that was presented during CNS Summit 2016, which was held October 27 […]

Continue Reading